Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Finch Therapeutics Group

Request full access

A clinical-stage microbiome therapeutics company leveraging its Human-First Discovery platform to develop a novel class of orally administered biological drugs

Boston, United StatesFounded 2004Biotech & Life Sciences

About Finch Therapeutics Group

Finch Therapeutics is a biotechnology company focused on developing microbiome-based therapeutics. The company operates in the healthcare and pharmaceutical market, targeting conditions such as recurrent C. difficile infection, chronic hepatitis B, inflammatory bowel disease, and autism-related gastrointestinal symptoms. Finch's unique approach involves utilizing data from human interventional studies and a machine learning-based platform to understand the microbiome communities that drive positive clinical outcomes. This 'Human First' discovery platform allows Finch to start drug development with a clinical understanding rather than a purely laboratory-based approach. The business model primarily revolves around research and development, clinical trials, and partnerships with other pharmaceutical companies. Finch generates revenue through the development and commercialization of its therapeutic products, as well as through collaborations and licensing agreements. The company's clients include healthcare providers, patients, and pharmaceutical partners.

Source: Dealroom company data

Finch Therapeutics Group in the Boston ecosystem

Live from Dealroom

The Finch Therapeutics Group office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Shumway Capital
  • Avenir Growth Capital
  • Morgan Noble

Series B and later11 investors entered at this stage

  • OCV Partners
  • Trans Pacific Technology Fund
  • Willett Advisors
  • The Baupost Group
  • Humboldt Fund
  • MSD Partners
  • OMX Ventures
  • SIG Group
  • DFO Management
  • SymBiosis
  • Octave Group
Team profiled 15 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States91.7%
🇵🇰 Pakistan8.3%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Finch Therapeutics Group on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Finch Therapeutics Group on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.